Introduction
Glioblastoma multiforme (GBM) is the most common malignant tumor in the central nervous system, which accounts for ~50% of glioma. 1 The canonical treatment of GBM is surgery accompanied by chemotherapy and radiotherapy. The promising prognosis of patients with GBM is poor due to its high proliferation and invasion ability as well as the insensitivity to chemoradiotherapy. As recently estimated, the median survival is about 12-16 months. 2 Hence, new strategies for GBM treatment are urgent to be discovered. Baicalin (7-glucuronic acid-5,6-dihydroxy-flavone) is the major bioactive flavone derived from the root of Scutellaria baicalensis, 3 which is commonly used in the traditional Chinese medicine. As previously reported, baicalin harbors remarkable Drug Design, Development and Therapy 2018:12 submit your manuscript | www.dovepress.com
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Zhu et al bioactivities, including antioxidation and anti-inflammation, with little toxicity to normal tissues. 3, 4 Recently, the anticancer function of baicalin is emerging in breast cancer, 5 colon cancer, 6 and hematological malignancies. 7 However, the potential mechanism underlying the cancer cytotoxicity remains unclear, which partially attributes to the autophagy induction ability of baicalin. 8, 9 Autophagy is a protective conserved process that eliminates physiological byproducts of metabolism. 10 Autophagy is a process that initiates with the double-membraned organelles containing the disposable cytoplasmic entities and then these organelles fuse with lysosomes to degrade the cargo. Microtubule-associated protein 1A/1B-light chain 3 beta (LC3B) serves as the biomarker of the end stage of autophagosome formation.
11 LC3B-II, the maturation form of LC3B, locates on the somatic membrane of autophagosomes that represents the activity of autophagy.
Autophagy plays a double-edged role in tumor initiation and progression. It is essential for autophagy to inhibit oncogenesis in pre-malignant cells, but sustain the cancer progression by protecting cancer cells from metabolic stress and by feeding cellular metabolism and repair mechanisms. 11 However, excessive activation of autophagy can lead to cell death (type 2 cell death), which is different from apoptosis (type 1 cell death) according to the morphological status. 11 Autophagy and apoptosis frequently occur in a hierarchical or independent fashion to contribute to cell death. Nevertheless, excessive autophagy may act as an accomplice upstream of apoptotic cell death, even though inhibition of autophagy can enhance the apoptosis induced by cytotoxic constituents in some cases. Collectively, the relationship between autophagy and apoptosis is complicated for the sake of discrepancies in cell type, stimulus, and environment. 12 It is well understood that autophagy is regulated by an intricate control map. Mechanistic target of rapamycin (mTOR) is the best-characterized repressor of autophagic flux.
11 PI3K/Akt pathway reduces apoptosis, promotes the survival of cells, and activates downstream mTOR to regulate autophagy. 13 In addition, baicalin downregulated PI3K/Akt/ mTOR pathway as previously reported. 14 Calcium is a versatile intracellular second messenger, and it is involved in many pathophysiological processes including gene transcription, and cell differentiation and death. 15 An increase in the intercellular Ca 2+ levels causes ER stress and constitutes prominent proapoptotic signals, 16 which were proven in abundant number of studies. Moreover, Ca 2+ overload in the cytosol can induce autophagy potentially via the AMPK/mTOR pathway. Ca 2+ binds to calmodulin (CaM) and activates AMPK, which then inhibits mTOR and triggers autophagy. 17 Ca 2+ is an intermingled stimulator of apoptosis and autophagy, and whether baicalin can increase intercellular Ca 2+ is still unknown. In this present study, we investigated the antineoplastic effect of baicalin of glioblastoma in vitro. The findings here demonstrated that baicalin reduced glioblastoma growth and motility in a dose-dependent manner. Baicalin activated autophagy and apoptosis, while inhibition of autophagy by 3-methyladenine (3-MA) unequivocally decreased the apoptosis. Moreover, Ca 2+ -dependent pathway is the potential mechanism underlying baicalin-induced apoptosis and autophagy, which was confirmed by the fact that chelation of Ca 2+ by 1,2-bis(o-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid (BAPTA) significantly decreased apoptosis and autophagy after baicalin treatment.
Materials and methods cell culture
U87 and U251 human glioblastoma cell lines were purchased from the Cell Bank of Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China). Normal human astrocyte (NHA) primary cultures were gained from the Institute of Basic Medical Sciences (Beijing, China). U87 and U251 were cultured in Dulbecco's Modified Eagle's Medium (DMEM; Thermo Fisher Scientific, Waltham, MA, USA), supplemented with 10% fetal bovine serum (Thermo Fisher Scientific) and 1% penicillin/streptomycin (HyClone, GE Healthcare Life Sciences, Logan, UT, USA). NHA were grown in the Astrocyte Medium (AM, Sciencell, San Diego, CA, USA) as utilized elsewhere. 18 The cells were incubated at 37°C in a humidified atmosphere of 95% air and 5% CO 2 .
regents and antibodies
Baicalin and 3-MA were purchased from Sigma-Aldrich Co. (St Louis, MO, USA). BAPTA-AM was purchased from Selleck Chemicals (Shanghai, China). Anti-Bax, anti-Bcl-xl, anti-cleaved caspase 3, anti-PARP, anti-mTOR, anti-pmTOR, anti-AKT, anti-p-AKT, anti-cyclin D1, anti-cyclin B1, anti-cyclin A, anti-ZO-1, anti-Catenin, anti-Vimentin, and anti-β-actin antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA). Anti-LC3B, anti-MMP-2, and anti-beclin 1 antibodies were purchased from Novus Biologicals (Littleton, CO, USA). Anti-HMGB1 and antip62/SQSTM1 antibodies were purchased from Abcam (Cambridge, MA, USA 
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cell viability assay
Cell viability was done with the Cell Counting Kit-8 (CCK-8; Dojindo, Kumamoto, Japan) following the manufacturer's instruction. NHA, U87 and U251 cells were seeded in the 96-well plates at 5×10 3 cells for 24 hours before baicalin administration. Baicalin was diluted in the DMEM into the concentrations of 0, 25, 50, 100, 150, 200, and 300 µM. After treatment for 48 hours, we removed the previous medium and then added 10% CCK-8 diluted with DMEM 100 µL per well. After incubating at 37°C for 2 hours, the plates were analyzed with Bio-Rad ELISA microplate reader at the value of 450 nm wavelength (OD450). We calculated the viability with the following formula: cell viability = (OD450 of treated groups/OD450 of control group)×100%.
colony-forming assay
U87 and U251 cells were seeded onto the six-well plates at a density of 1,000 cells per well. We changed the medium (0, 50, 100, 150, 200, and 300 µM baicalin) every 3 days and incubated the plates for 12 days. After methanol fixing for 20 minutes, the colonies were stained with 0.1% crystal violet (Beyotime, Shanghai, China) for photographing.
Migration and invasion assay
Transwell assays were employed to evaluate the motility and invasive captivity of U87 and U251 cells when treated with baicalin. For migration assay, a total of 2×10 5 cells in 200 µL DMEM were added into the upper chamber of 6.5 mm transwells with 8.0 µm pore polycarbonate membrane inserts (Corning Incorporated, Corning, NY, USA). However, for invasion assay, the upper chambers were covered with additional matrigel matrix (Corning Incorporated). After incubating at 37°C for 16 hours, we cleaned up the cells in the interior of the chamber that did not penetrate the membrane. Subsequently, the chambers were fixed with paraformaldehyde for 15 minutes and then stained with 0.1% crystal violet for 10 minutes. The migrating cells were observed in six microscopic fields (200×) under an inverted microscope by two investigators blind to the grouping (Carl Zeiss Meditec AG, Jena, Germany).
Flow cytometry
For cell cycle analysis, U87 and U251 cells were harvested and fixed with 75% ethanol. After propidium iodide (PI) staining, nuclei were analyzed using a FACSCalibur flow cytometer (BD Biosciences, San Jose, CA, USA).
For apoptosis analysis, cells were harvested and suspended with 500 µL of binding buffer containing 5 µL of Annexin V-FITC (AV) (KGA108, KeyGEN, China) and 5 µL of PI (BD Biosciences) and then the apoptotic cells were analyzed using a FACSCalibur flow cytometer (BD Biosciences).
For Ca 2+ content analysis, about 2 µM Ca 2+ indicator, fluo-2 (KGAF022, KeyGEN, Nanjing, China), was loaded into the U87 and U251 cells for 60 minutes at 25°C, and the level of intracellular Ca 2+ was finally estimated by flow cytometry (BD Biosciences) using FL2 fluorescent intensity.
Western blot
Western blot assays were operated as described elsewhere. 19 In brief, U87 and U251 cells were treated with 0, 25, 50, 100, 200, and 300 µM baicalin for 48 hours and then harvested. Equal amounts of samples were subjected to electrophoresis on 8%-12% SDS-PAGE gels and then transferred onto a PVDF membrane (EMD Millipore, Billerica, MA, USA). After blocked with 5% skim milk for 2 hours at room temperature, the blots were incubated at 4°C overnight with separate primary antibodies. After washing with TBST, membranes were incubated with the corresponding secondary HRP-conjugated antibodies. Finally, the protein bands were visualized using enhanced chemiluminescence detection reagents (EMD Millipore) using a chemiluminescence imaging system (Tanon, Shanghai, China).
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUnel) analysis
The apoptotic cells were observed by fluorescence stain using a TUNEL detection kit (Roche, Indianapolis, IN, USA) according to the method described elsewhere. 20 The extensive DNA fragmentation of the U87 and U251 cells was featured with condensed nuclei. All the slides and tumor sections were observed in six microscopic fields (400×) by two investigators blind to the grouping.
Immunofluorescence
U87 and U251 cells were seeded onto the glass cover slips and allowed to attach overnight. After separate concentration of baicalin (0, 100, 200, and 300 µM) treatment for 48 hours, the cells were fixed with 4% paraformaldehyde for 15 minutes and then treated with 0.3% Triton X-100 for 10 minutes. The primary antibodies of LC-3B was incubated at 4°C overnight following by the CY3-conjugated secondary antibody for Drug Design, Development and Therapy 2018:12 submit your manuscript | www.dovepress.com
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immunohistochemical staining
For immunohistochemistry analysis, the U87 xenograft tumor tissue sections (4-6 µm) were incubated with anti-Ki-67 antibody (1:200, Cell Signaling Technology, Inc., Danvers, MA, USA) overnight at 4°C. The sections were incubated with HRP-conjugated IgG (1:500, Santa Cruz) for 1 hour followed by washing in phosphate-buffered saline (PBS) for two times, 10 minutes each. Ki-67 was stained with diaminobenzidine and cell nuclei were counterstained with hematoxylin.
Measurement of mitochondrial membrane potential
We used the mitochondrial membrane potential assay kit with 5,5′,6,6′-Tetrachloro-1,1′,3,3′-tetraethylimidacarbocyanineiodide (JC-1) (Beyotime) to analyze the effect of baicalin on mitochondria following the manufacturer's instruction. U87 and U251 cells were administrated with baicalin (0, 100, 200, and 300 µM) for 48 hours and then were subjected to the JC-1 staining in the incubator for 30 minutes. The aggregates (red) and the monomer (green) were visualized under the ZEISS immunofluorescence microscope (400×).
Tumor xenografts study
All experimental procedures and protocols involving mice were reviewed and approved by the Animal Investigation Ethics Committee of Jinling Hospital and were conformed to the Guide for the Care and Use of Laboratory Animals by the National Institutes of Health. A total of 1×10 7 U87 cells were suspended in 100 µL of PBS and injected subcutaneously in the right flank of male BALB/c athymic nude mice (Charles River Breeding Laboratories, Wilmington, MA, USA) at the age of 4-6 weeks. The tumor volume (V) was calculated by the following formula: V (mm 3 ) = (major axis) × (minor axis) 2 × 0.5236. We evaluated the tumor volume and body weight every 3 days. The mice were randomly assigned into three groups (0, 50, and 100 mg/kg of baicalin). Once the tumor was palpable, different concentrations of baicalin were intraperitoneally injected into the nude mice every 24 hours for 10 consecutive days. Finally, the nude mice were euthanized and the tumors were dissected, weighed, and photographed.
statistical analysis
The SPSS version 22.0 (IBM Corporation, Armonk, NY, USA) software was employed to analyze all the data. Data are expressed as mean ± SEM and evaluated by Student's t-test and ANOVA for multiple comparisons. P,0.05 was considered as a gauge of statistical difference.
Results
Baicalin inhibits the proliferation of glioblastoma cells
To investigate the inhibitory role of baicalin on human glioblastoma cell lines (U87 and U251), we employed the CCK-8 assay to determine the cell viability. Baicalin was added into the cell medium in a concentration gradient (0, 25, 50, 100, 150, 200, and 300 µM) for 48 hours. We found that baicalin significantly reduced cell viability to about 50% in a dose of 300 µM ( Figure 1A and B) . Besides, we used NHAs to evaluate the biotoxicity of baicalin. Our results showed that baicalin did not influence the viability of NHAs to the dose of 300 µM ( Figure 1C) .
The colony-forming assay was employed to determine the long-term repressive role of baicalin on U87 and U251. Separate concentrations of baicalin (0, 50, 100, 150, 200, and 300 µM) were administrated to the six-well plate for 12 days. As shown in Figure 1D and E, the size and the number of colonies were much smaller after treatment with baicalin than the control group.
Baicalin blocks the cell cycle of glioblastoma cells in s phase
To evaluate the effect of baicalin administration on cell cycle profile, we utilized the flow cytometry to analyze the cell cycle distribution of glioblastoma after pretreated with 0, 100, 200, and 300 µM baicalin for 48 hours. The observation showed that in U251 cell line treated with different doses of baicalin, the percentage of cells in S phase increased in a dosedependent manner ( Figure 1F ). We subsequently examined the cyclin A, cyclin B1, and cyclin D1 protein level, which directly regulated the S-phase transition. 21 We found that baicalin obviously restrained the expression of cyclin A, cyclin B1, and cyclin D1 ( Figure 1G and H) . However, the S-phase blockage did not apply to U87 cells (data not shown). Taken together, all these results suggested that baicalin reacted on the S-phase arrest in the U251 glioblastoma cell line.
Baicalin suppresses the migration and invasion ability of glioblastoma cells
The motility of U87 and U251 cells were measured by transwell assays. After treatment with separate doses of baicalin (0, 100, 200, and 300 µM) for 16 hours, the cells that penetrated the polycarbonate membrane with or without matrigel matrix were visualized by microscope in the 200× magnification. As shown in Figure 2A 
(G, H)
The expression of s-phase arrest proteins, cyclin D1, cyclin B1, and cyclin a, was reduced after baicalin treatment in a dose-dependent manner. The relative protein levels of control cells were adjusted to the value of 1. Data were represented as the means ± seM of three independent experiments. *P,0.05, **P,0.01, ***P,0.001 vs control group (0 µM baicalin). Abbreviations: ccK-8, cell counting Kit-8; nha, normal human astrocyte. 
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Zhu et al and invasion ability was dose dependently suppressed by baicalin. We then counted the cells in six different fields every chamber and found that baicalin inhibited the motility of glioblastoma statistically ( Figure 2C and D) . Next, we analyzed several protein levels that related to the migration and invasion ability. The expression of ZO-1, β-catenin, Vimentin, HMGB 1, and MMP 2 were detected by Western blot (Figure 2E and F) and we observed a significant decrease of all the protein levels ( Figure 2G and H) . Collectively, our observations indicated that baicalin suppressed the migration and invasion of glioblastoma cells in a concentration-dependent manner.
Baicalin induces mitochondrial apoptosis in glioblastoma cells
As mentioned above, baicalin suppressed the glioblastoma growth; however, whether baicalin played a role in the induction of apoptosis still needed investigation. Bcl-xl is the antiapoptotic protein in the Bcl-2 family, while Bax is the pro-apoptotic protein. They locate in the outer membrane of mitochondria and control the permeability of cytochrome c through mitochondrial voltage-dependent anion channel. The release of cytochrome c activates PARP and caspase 3, thus triggering the apoptotic cascade. Here, we found that baicalin increased the expression of Bax and decreased Bcl-xl, which promoted the release of cytochrome c from mitochondria. The activated form of PARP and caspase 3 were upregulated in a dose-dependent manner ( Figure 3A-D) .
Besides, the mitochondrial apoptosis attributes to the loss of mitochondrial membrane potential (∆ψ m) that regulates the release of cytochrome c. We then analyzed the JC-1 as a molecular probe of ∆ψ m. As shown in Figure 3E , the monomer of JC-1 was formed and visualized in green when the ∆ψ m was destroyed after treatment with baicalin (0, 100, 200, 300 µM).
To verify the proapoptotic effect of baicalin, we then employed TUNEL analysis to show the late-phase apoptosis of cells. Figure 3F and G showed that the TUNEL-positive cells were increased significantly after treatment with 200 µM baicalin. Collectively, the above findings demonstrated that baicalin induced mitochondrial apoptosis in glioblastoma cells.
Baicalin induces autophagy-related apoptosis via the Pi3K/akt/mTOr pathway
We then ascertained the autophagy induction role of baicalin. First, we analyzed the expression of LC3B-II, the biomarker of autophagosome formation, by Western blot and immunofluorescence. Figure 4A showed that baicalin induced autophagy in a dose-dependent manner. We also found that beclin 1 protein level was increased and p62, the scaffold protein of autophagosome, was decreased, which suggested the activation of autophagy. Besides, PI3K/Akt/ mTOR pathway was reported to be involved in the regulation of both autophagy and apoptosis. Therefore, this pathway was studied and we found that the phosphorylation of AKT and mTOR were decreased ( Figure 4B-E) , which further certified the apoptosis and autophagy induced by baicalin. However, the relationship between apoptosis and autophagy induced by baicalin was still unclear. (A, B) The intercellular ca 2+ was measured by flou-2 fluorescence and flow cytometry. Baicalin (0, 100, 200, and 300 µM) was added onto cells for 48 hours and then subjected to analysis. The relative level of ca 2+ content was increased, which is represented by the size and brightness of the ca 2+ dots (A) or M1 percentage (B), M1 represents the relative percentage of ca 2+ content, which was defined by positive distribution of Ca 2+ in the 0 µM group (the peak value in the 0 µM group was defined as the negative distribution). (C-I) U87 and U251 cells were pretreated with ca 2+ chelator 5 µM BaPTa for 1 hour and then subjected to 0 or 200 µM baicalin for 48 hours. cells were divided into four groups: control, BaPTa, Baicalin, and Baicalin+ BaPTa group. (C) The apoptotic cell ratio of the four groups was measured by flow cytometry. The Baicalin+ BAPTA group showed a less apoptotic ratio compared with the Baicalin group. The right upper and right lower quadrants of each figure represent the apoptotic cell ratio. (D, E) ccK-8 assay showed that when pretreated with BaPTa, the cell viability was increased after baicalin treatment compared with baicalin alone group. BaPTa pretreatment did not show cytotoxicity to glioblastoma cells. (F-I) autophagy-related protein levels of mTOr and lc3B were restored when pretreated with BaPTa compared with baicalin group. Proapoptotic protein levels of ParP, Bax, and cleaved caspase 3 were downregulated while the antiapoptotic protein level of Bcl-xl was upregulated when pretreating with BaPTa. The relative protein levels of control cells were adjusted to the value of 1. Data were represented as the means ± seM of three independent experiments. *P,0.05, **P,0.01, ***P,0.001 vs control group. was analyzed by flow cytometry following Annexin V/PI staining and the results showed that apoptotic cell ratio was decreased after baicalin treatment with additional 3-MA while 3-MA alone did not show the effect ( Figure 4F ). CCK-8 assay revealed that the combination treatment of baicalin and 3-MA restored the cell viability, which was inhibited by baicalin alone (Figure 4G and H). As shown in Figure 4I -L, LC3B-II was inhibited by 3-MA, and decreased Bax and upregulated Bcl-xl were observed after additional 3-MA treatment compared with baicalin alone. Taken together, these observations suggested that autophagy induced by baicalin was partially a prerequisite to cell apoptosis.
Baicalin increases intercellular ca 2+ content in glioblastoma cells
Calcium is a stimulator of both autophagy and apoptosis and whether calcium is the initiator of cytotoxicity ignited by baicalin needs uncovering. We then employed flou-2 fluorescence and flow cytometry to determine the Ca 2+ content, U87 and U251 cells showed an increased intercellular Ca 2+ after baicalin administration in a dose-dependent manner ( Figure 5A and B) . BAPTA-AM, a kind of Ca 2+ chelator that can penetrate cell membrane, was used to chelate intercellular free Ca 2+ to antagonize the baicalin-induced Ca 2+ overload. Cells were pretreated with 5 µM BAPTA for 1 hour and then treated with or without baicalin for 48 hours. Our observations showed that BAPTA pretreatment significantly decreased the apoptotic ratio and restored the cell viability compared with baicalin alone ( Figure 5C -E). Autophagyrelated protein levels of p-mTOR, LC3B were restored ( Figure 5F -I) and suggested that BAPTA pretreatment inhibited the activation of autophagy. Moreover, apoptosisrelated protein levels of PARP, Bcl-xl, Bax and cleaved caspase 3 were also restored ( Figure 5F -I) and suggested that BAPTA pretreatment suppressed apoptosis induced by baicalin. Hence, the intercellular Ca 2+ overload contributed to the autophagy and apoptosis induced by baicalin in U87 and U251 cells. When the free Ca 2+ was chelated, autophagy and apoptosis were inhibited.
Baicalin inhibits tumor growth in tumor xenografts study
Next, we aimed to determine the effects of baicalin on glioblastoma growth in vivo, the immune-deficient nude mice bearing U87 tumor xenografts were employed. The detailed procedure of the xenograft mouse model was elucidated above. As shown in Figure 6A and B, D, the tumor volume and weight were significantly inhibited by intraperitoneal injection of saline or baicalin (50, 100 mg/kg). The total body weight of nude mice did not change overtly ( Figure 6C ). The tumors of the xenografts were then fixed by paraffin for section analysis. The immunohistochemical staining showed that baicalin lowered the expression of Ki-67, which serves as a vital biomarker of cancer cell proliferation ( Figure 6E and F) . 
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Discussion
Glioblastomas are lethal brain tumors characterized by angiogenesis and pseudopalisading necrosis and surgical resection remains the mainstay of treatment for patients with glioblastoma. 22 Recent studies on glioblastoma treatment mainly focused on the emerging nanomedicine and therapies that capitalize on cell-specific signaling and immunotherapy targeted on GBM and glioma stem cell (CSC). [22] [23] [24] Notably, the extracted bioactive regents of Chinese traditional medicine play a vital role in the treatment of glioblastoma. 25 In this work, we demonstrated that baicalin repressed the proliferative and invasive rate of human glioblastoma cells in vitro and vivo in dose-dependent manners. Baicalin induced the S-phase blockage and mitochondrial apoptosis; moreover, baicalin triggered the synergistic cytotoxicity of autophagy and apoptosis potentially through the Ca 2+ -dependent pathway. Interestingly, we found that baicalin induced S-phase arrest in cell cycle only in the U251 cell line, while the U87 cell line did not show the same S-phase inhibition. This discrepancy may be due to the different regulatory mechanism of cell growth inhibition in specific glioblastoma cell type. Further studies are needed to delineate the potential mechanism of the difference in cell cycle arrest in U87 and U251 cells.
ROS is a byproduct of the mitochondrial metabolism. Excessive ROS production may lead to apoptosis with the opening of mitochondrial permeability transition pore, thus releasing cytochrome c to trigger the activation of caspase 3.
26
Baicalin is canonically regarded as the ROS scavenger with its phenolic structure capable to transfer electron-free radicals 27 as verified by its little toxicity to NHA. In the colon cancer, baicalin in a dose of 40 µM could enhance superoxidase dismutase activity and decrease ROS content. 6 However, 250 µM of wogonoside (another flavonoid from Scutellaria) administration to glioblastoma could increase the ROS production and induce mitochondrial apoptosis. 25 This possibly attributes to the phenoxy radicals generated by peroxidase that serves as pro-oxidants or the depletion of glutathione content 28 or excessive autophagy. Interestingly, we found that baicalin induced mitochondrial apoptosis with the dissipation of mitochondrial membrane potential (∆ψ m) potentially via the induction of excessive autophagy. Nevertheless, the role of ROS in the glioblastoma apoptosis caused by baicalin still needs delineation with detail in further study.
An abundant literature reveals that flavonoids such as baicalin and baicalein can induce autophagy in solid tumors. 29 In this present study, we demonstrated that baicalin triggered autophagy in a dose-dependent manner. The maturation of LC3B, the increased expression of beclin 1, and the degradation of p62 together indicated that the increased formation of autophagosome. In addition, beclin 1 functions as a tumor suppressor. Knocking down of beclin 1 gene in mice spontaneously develops various cancers, including lung cancer and lymphoma. Its role in the elongation of forming autophagosome with phosphatidylinositol 3-phosphate is well elucidated; 30 however, beclin 1 contains the BCL2 homology-3 domain, which is capable of binding to the antiapoptotic 
3260
Zhu et al protein (Bcl-2 and Bcl-xl), thus favoring apoptosis to some extent. 31 Collectively, the induction of autophagy may exert an influence on apoptosis with baicalin treatment on glioblastoma and whether autophagy itself could lead to cellular demise is still an issue to be resolved.
When glioblastoma cells suffer from cellular stress such as treatement with temozolomide, autophagy always preserves homeostasis by providing the cell-intrinsic cytoprotection and by changing the microenvironmental conditions, thus leading to chemotherapy resistance and immunosurveillance. 12, 32 However, in some circumstances, massive autophagy kills cells in a way of self-destruction or, alternatively, hardwiring of autophagy to proapoptotic cascade. 12 Here, this study demonstrated that inhibition of autophagy by 3-MA could decrease apoptosis, which indicated that autophagy is prior to apoptosis induced by baicalin to certain extent. Autophagy-related apoptosis is mainly determined by the autophagosome forming in the apoptotic cells and the restoration of cell apoptosis via suppression of autophagy. Taken together with aforementioned mechanisms, these results suggest that baicalin shows cytotoxicity to human glioblastoma cells in a synergistic effect of apoptosis and autophagy.
As previously documented, a mixed phenotype of autophagy and apoptosis could be detected following the treatment of the same stimuli. Intriguingly, the common mechanism underlying baicalin-induced cytotoxicity is still little investigated. Chang et al reported that baicalein (aglycone form of baicalin) induced Ca 2+ flux into the cell through the PKC-dependent, 2-APB-sensitive store-operated Ca 2+ channels. Moreover, the release of Ca 2+ from the ER to cytosol is dependent on the PLC pathway. 33 Increase in the free Ca 2+ concentrations always leads to aggravated ER stress and the disturbance of mitochondrial membrane potential, thus leading to mitochondrial apoptosis. 34 HoyerHansen et al demonstrated that unwanted cytoplasmic Ca 2+ led to autophagy via the activation of CaM-dependent kinase kinase-β and inhibition of mTOR. 17 In addition, several studies indicated that calpains stimulated by cytoplasmic Ca 2+ could significantly conduce autophagy and apoptosis. 35 Here, in this study, we found that baicalin treatment in the glioblastoma cells significantly increased the cytosolic Ca 2+ content. When pretreated with BAPTA, cells suffered less from baicalin-induced autophagy and apoptosis. However, our work did not go deep into the efflux of intercellular Ca 2+ between ER and mitochondria, which were connected by mitochondria-associated membrane. 36 Besides, BAPTA pretreatment restored the expression of phosphorylated mTOR without the restoration of phosphorylated AKT (data not shown). This suggests that Ca 2+ overload may trigger the AMPK/mTOR pathway instead of PI3K/Akt pathway. Collectively, these clues above lend to the hypothesis that Ca 2+ overload is the profound mechanism underlying the autophagy and apoptosis induced by baicalin.
To sum up, the findings in our study showed baicalin suppressed the proliferation, migration, and invasion ability of glioblastoma in a dose-dependent manner and the synergistic effect of apoptosis and autophagy induced by baicalin contribute to its cytotoxicity to human glioblastoma cells. The strong evidence proves that baicalin, the natural extracted flavonoid, is a promising therapeutic agent for the treatment of glioblastoma.
